Cannabis and Professional Licenses: Nurses, Lawyers, Pilots, and More
Policy / Culture
Your License
Licensed professionals in healthcare, aviation, law, and commercial driving can lose the licenses their careers depend on for cannabis use that is entirely legal under state law.
FAA, Federal Aviation Regulations; FMCSA CDL Protocol
FAA, Federal Aviation Regulations; FMCSA CDL Protocol
View as imageLicensed professionals occupy an unusual position in the cannabis legalization landscape. You can live in a state where cannabis is fully legal, purchase from a licensed dispensary, consume responsibly on your own time, never be impaired at work, and still face the loss of the license that your career depends on. This happens because professional licensing boards operate under their own rules, and those rules often do not track with state cannabis law.
The degree of risk varies dramatically by profession. Understanding where your specific license falls on this spectrum is essential for making informed decisions about cannabis use.
Key Takeaways
- Licensing boards in most states can discipline professionals who use cannabis even where it's legal, because licensing standards often reference federal law or professional ethics codes
- Healthcare workers — nurses, physicians, pharmacists — face the tightest rules because boards treat substance use as a patient safety issue, and most require mandatory reporting of impairment
- Pilots, air traffic controllers, and anyone with an FAA certificate are under federal zero-tolerance drug testing with no exceptions for state-legal cannabis or medical cards
- Lawyers are in a more nuanced spot — bar associations in legal states are increasingly deciding that lawful cannabis use isn't a character issue, but use that affects your competence is still grounds for discipline
- Commercial drivers with a CDL face FMCSA-mandated random drug testing with zero THC tolerance, and a single positive test pulls you off safety-sensitive duties immediately
- The overall trend is toward separating off-duty legal use from on-duty impairment, but that shift is happening at very different speeds depending on the profession and the state
Healthcare Professionals: Nurses, Physicians, and Pharmacists
Cannabis Risk by Professional License Type
The trend: Legal states are slowly separating off-duty legal use from on-duty impairment. But federal-license professions (FAA, FMCSA, DEA) remain zero-tolerance with no state-level exceptions.
Healthcare licensing boards apply the most aggressive scrutiny to cannabis use among their licensees. The reasoning is straightforward from the board's perspective: healthcare professionals have access to controlled substances, make decisions affecting patient safety, and are held to a higher standard of conduct.
Registered nurses and nurse practitioners face significant risk. State boards of nursing in most states have authority to investigate and discipline nurses for substance use, including cannabis. Many boards require nurses to self-report any substance use that could affect their practice. In some states, a positive drug test at work triggers mandatory referral to an impaired professional program, which typically involves monitoring, random testing, and practice restrictions for three to five years.
The practical reality varies by state. In legal states like Colorado and Oregon, some boards have softened their approach to off-duty cannabis use that does not affect job performance. But in most states, a positive THC test, even from use during off-hours, is treated as a substance abuse concern that warrants investigation. Boards of nursing frequently do not distinguish between on-duty impairment and evidence of off-duty use.
Physicians face a similar framework but with some additional nuances. State medical boards can discipline physicians for unprofessional conduct, which is broadly defined in most states. However, physicians also benefit from greater resources to challenge board actions. The American Medical Association has not taken a position against lawful cannabis use by physicians, and some state medical boards in legal states have issued guidance indicating they will not pursue disciplinary action for lawful off-duty use absent evidence of impairment affecting patient care.
Pharmacists are in an especially complex position because they hold licenses from state pharmacy boards that are closely aligned with federal drug scheduling. Cannabis remains Schedule I under the Controlled Substances Act, and pharmacists' professional obligations include compliance with federal drug law. Some pharmacy boards have taken the position that any cannabis use by a pharmacist is inconsistent with professional standards, even in legal states.
Attorneys and the Character and Fitness Question
The legal profession's approach to cannabis use has evolved more rapidly than most other licensed professions, particularly in states with recreational legalization.
Bar admission requires applicants to pass a character and fitness evaluation. Historically, drug use including cannabis was treated as a character issue that could prevent admission. This has changed substantially. Bar associations in most legal states no longer treat lawful cannabis use as a disqualifying factor in character and fitness evaluations. The Alaska Bar Association, Oregon State Bar, and several others have issued explicit guidance stating that lawful cannabis use will not be held against applicants.
For practicing attorneys, the relevant rule is typically the state's version of Model Rule 1.1 (competence) and Model Rule 8.4 (misconduct). Using cannabis lawfully during off-hours is generally not considered misconduct in legal states. However, cannabis use that impairs an attorney's competence to represent clients, causes them to miss deadlines, or affects their professional judgment can absolutely lead to disciplinary action, just as alcohol abuse would.
The key distinction the legal profession is increasingly drawing is between use and impairment. Lawful off-duty use is generally acceptable. Use that affects professional performance is not. This is essentially the same standard applied to alcohol and is a model that other professions may eventually adopt.
That said, attorneys who practice federal law, hold federal appointments, or maintain security clearances face additional restrictions beyond their state bar rules. And attorneys in states where cannabis is not legal face the straightforward rule that illegal drug use can be grounds for discipline.
Pilots and Aviation Professionals
Aviation is the most restrictive professional field for cannabis use, with no ambiguity and no trend toward relaxation.
The Federal Aviation Administration requires all pilots, air traffic controllers, flight engineers, and other certificate holders to comply with DOT drug testing regulations. These regulations mandate pre-employment testing, random testing, post-accident testing, and reasonable-suspicion testing. The substance panel includes THC, and there is no exception for state-legal cannabis use, medical cannabis recommendations, or off-duty consumption.
A positive THC test for an FAA certificate holder triggers immediate removal from safety-sensitive duties, mandatory referral to a substance abuse professional, and potential certificate suspension or revocation. The FAA treats any positive THC result as disqualifying regardless of the amount detected or the circumstances of use.
Medical cannabis use is particularly problematic for pilots because FAA medical certification requires disclosure of all medications and treatments. Using cannabis as a medical treatment is disqualifying for an FAA medical certificate. Even if a pilot's state allows medical cannabis, the FAA does not recognize it as a legitimate treatment, and using it makes the pilot ineligible to hold the medical certificate required to fly.
The timeline for returning to flight status after a positive THC test or disclosed cannabis use is lengthy. It typically involves completing an evaluation by a substance abuse professional, entering a monitoring program with random testing, maintaining documented sobriety for a minimum period (often 12 to 24 months), and receiving clearance from the FAA's Office of Aerospace Medicine.
Commercial Drivers: CDL Holders
Commercial motor vehicle operators holding a CDL are subject to Federal Motor Carrier Safety Administration drug testing regulations that closely mirror the FAA framework.
FMCSA regulations require pre-employment, random, post-accident, reasonable-suspicion, return-to-duty, and follow-up testing for THC among other substances. The confirmation cutoff for THC metabolites in urine testing under DOT protocols is 15 ng/mL, and there is no exception for state-legal cannabis use.
A positive test result triggers removal from safety-sensitive functions, mandatory evaluation by a substance abuse professional, and a return-to-duty process that includes a negative test before resuming driving. The positive test becomes part of the FMCSA Clearinghouse database, which all employers of CDL holders are required to query before hiring and at least annually for current employees. This means a positive result follows a driver across employers.
The FMCSA has been unambiguous in its position: state cannabis laws do not modify federal requirements for commercial drivers. A CDL holder who uses cannabis legally under state law and tests positive faces exactly the same consequences as one who uses it illegally.
Teachers and Education Professionals
Public school teachers and other education professionals face a middle-ground situation that varies significantly by state and school district.
Teaching licenses are issued by state departments of education, and most states include conduct standards that can be interpreted to encompass cannabis use. However, the practical enforcement of these standards against off-duty, lawful cannabis users is inconsistent.
In legal states, most school districts address cannabis through their employment policies rather than through licensing board actions. Many districts drug test during hiring but not randomly thereafter. A pre-employment positive for THC can disqualify a candidate in some districts, while others in legal states have stopped testing for THC entirely to avoid shrinking their applicant pool.
The risk for teachers is generally employment-based rather than license-based. A school board can terminate a teacher for violating district drug policy, and the teacher may or may not face a separate licensing board investigation depending on the circumstances and the state. Teachers in federally funded programs or those working under federal grants face additional restrictions similar to other federally connected positions.
Real Estate Agents, Accountants, and Other State-Licensed Professionals
Professionals licensed by state regulatory boards, including real estate agents, accountants, engineers, and architects, generally face lower cannabis-related risk than healthcare or transportation professionals.
Most state licensing boards for these professions have not issued specific guidance on cannabis use. Their disciplinary authority typically requires a nexus between the conduct in question and professional fitness. Off-duty, lawful cannabis use that does not affect professional performance is unlikely to trigger board action in most legal states.
However, criminal cannabis charges, even misdemeanors in non-legal states, can trigger mandatory disclosure and potential disciplinary review. And professionals who hold licenses in multiple states must comply with the standards of each licensing jurisdiction, which may have different rules.
The Federal Employment Overlay
Any professional who works for the federal government, holds a federal contract, or requires a federal security clearance faces a separate layer of restriction that overrides state law entirely.
The Drug-Free Workplace Act requires federal contractors and grantees to maintain drug-free workplace policies. Executive Order 12564 establishes a drug-free federal workplace. These requirements apply regardless of state cannabis law and regardless of whether the professional holds a state license that does not restrict cannabis use.
Federal employees and contractors in professional positions face the same zero-tolerance framework as transportation and aviation workers. A positive drug test or disclosed cannabis use can result in termination, loss of clearance, and in some cases, debarment from future federal work.
How to Assess Your Risk
The practical framework for evaluating cannabis-related risk to your professional license involves answering several questions. Is your profession regulated by a federal agency with drug testing requirements? If yes, cannabis use is incompatible with your license regardless of state law. Is your licensing board in a state where cannabis is legal? If yes, the risk is lower but not zero. Does your board have specific guidance on cannabis use? Check your board's website or call and ask. Does your employer drug test independently of your licensing board? Your job and your license are separate risks that may need to be evaluated independently.
For professionals in regulated fields who choose to use cannabis, the safest approach is to understand the specific rules governing your license, consume only in states where it is legal, avoid use within a time window that could result in a positive test during working hours, and never be impaired while performing professional duties.
The trend across most professions is toward treating cannabis more like alcohol, distinguishing between responsible off-duty use and impairment that affects professional conduct. But this trend is moving at different speeds in different fields, and being early to the trend offers little protection if your licensing board has not caught up.
This article is for informational purposes only and does not constitute legal advice. Professional licensing requirements vary by state, profession, and regulatory body. Consult an attorney experienced in professional licensing law in your jurisdiction for guidance specific to your situation.
The Bottom Line
Cannabis and professional licensing across healthcare, law, aviation, transportation, education, and other fields. Healthcare: boards of nursing — most aggressive scrutiny, mandatory reporting, positive test triggers impaired professional program (3-5yr monitoring/testing); some legal-state boards softening on off-duty use; physicians — similar framework but AMA has not opposed lawful use; pharmacists — most complex due to federal scheduling alignment. Attorneys: character and fitness evaluation evolving — AK, OR bars issued guidance that lawful use not disqualifying; practicing attorneys subject to competence/misconduct rules; trend toward use-vs-impairment distinction (same as alcohol); federal practitioners/security clearance holders face additional restrictions. Aviation: most restrictive field; FAA/DOT zero-tolerance testing (pre-employment, random, post-accident, reasonable suspicion); no exception for state law or medical cards; positive = immediate removal, substance abuse referral, potential certificate revocation; return to flight requires 12-24mo monitored sobriety. CDL holders: FMCSA-mandated testing, 15ng/mL confirmation cutoff; positive enters FMCSA Clearinghouse (follows driver across employers); no state law exception. Teachers: middle ground, varies by district; employment-based risk more than license-based; some legal-state districts stopped THC testing to maintain applicant pool. Other state-licensed professionals (RE agents, accountants, engineers): lower risk, boards typically require nexus to professional fitness; off-duty lawful use unlikely to trigger action in legal states. Federal overlay: Drug-Free Workplace Act, EO 12564 — federal employees/contractors face zero-tolerance regardless of state law or license type.
Frequently Asked Questions
Sources & References
- 1RTHC-07595·Schmidt, Laura A et al. (2025). “Child Cannabis Poisonings Increased Significantly After California Legalization.” American journal of preventive medicine.Study breakdown →PubMed →↩
- 2RTHC-07597·Schöllner, Natalie S et al. (2025). “Cannabis Use in Germany Increased Dramatically Across Both Time Periods and Birth Cohorts.” Addiction (Abingdon.Study breakdown →PubMed →↩
- 3RTHC-07609·Sedani, Ami E et al. (2025). “Cannabis Co-Use Made Smokers Less Likely to Quit Cigarettes.” Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.Study breakdown →PubMed →↩
- 4RTHC-07612·Segura, Luis E et al. (2025). “Women's Cannabis Use Increased More Than Men's After Recreational Legalization.” International journal of mental health and addiction.Study breakdown →PubMed →↩
- 5RTHC-07713·Stampf, Alisa et al. (2025). “Cannabis Treatment Demand Nearly Tripled in Germany Over 20 Years, With Patients Getting Older.” European archives of psychiatry and clinical neuroscience.Study breakdown →PubMed →↩
- 6RTHC-07987·Xu, Carol et al. (2025). “Recreational Cannabis Laws Are Associated With People Sleeping About 5 Minutes Less.” AJPM focus.Study breakdown →PubMed →↩
- 7RTHC-07604·Schweiger, Vittorio et al. (2025). “Medical Cannabis for Chronic Pain: What the Evidence and the Law Say.” Clinical and experimental rheumatology.Study breakdown →PubMed →↩
- 8RTHC-07562·Samples, Hillary et al. (2025). “Medical Cannabis Laws Linked to Less Frequent Opioid Misuse.” International journal of mental health and addiction.Study breakdown →PubMed →↩
Research Behind This Article
Showing the 8 most relevant studies from our research database.
Characteristics and Trends in Child Cannabis Exposures During Legalization in California.
Schmidt, Laura A · 2025
Monthly rates of moderate/severe cannabis exposure per million children increased significantly after legalization (beta=0.06; 95% CI: 0.05, 0.08).
Age-period-cohort analysis of past 12-month cannabis use in Germany (1995-2021).
Schöllner, Natalie S · 2025
Period effects showed cannabis use odds rising from OR 0.33 in 1995 to OR 2.96 in 2021.
Cannabis Use and Subsequent Cigarette Discontinuation Among U.S. Adults in the Population Assessment of Tobacco and Health Study, Waves 1-5.
Sedani, Ami E · 2025
Cannabis co-use was associated with decreased odds of cigarette discontinuation (aOR: 0.81, 95% CI: 0.72-0.93, p=0.0018) and decreased odds of discontinuing all combustible tobacco products (aOR: 0.75, 95% CI: 0.65-0.86, p<0.0001).
Gender differences in cannabis outcomes after recreational legalization: a United States repeated cross-sectional study, 2008-2017.
Segura, Luis E · 2025
RCL enactment was associated with higher increases in past-year cannabis use in women (aOR 1.30, 95% CI: 1.19-1.41) than men (aOR 1.15, 95% CI: 1.06-1.25), and similarly for past-month use.
Cannabis-related treatment demand at the eve of German cannabis legalization - a 20-years trend analysis.
Stampf, Alisa · 2025
CUD is the second-most common cause for outpatient addiction treatment in Germany.
The Effects of Cannabis Access Laws on Sleep in the U.S.
Xu, Carol · 2025
Recreational cannabis laws reduced sleep by 5.37 minutes per night (99% CI: 0.91-9.83), primarily by delaying sleep onset by 7.14 minutes without changing wake times.
Association Between Legal Access to Medical Cannabis and Frequency of Non-Medical Prescription Opioid Use Among U.S. Adults.
Samples, Hillary · 2025
Medical cannabis laws were associated with a 1.5 percentage point decrease in frequent non-medical prescription opioid use and a 2.1 percentage point increase in occasional use, suggesting a shift in use patterns rather than overall reduction..
Municipal socioeconomic environment and recreational cannabis use in Mexico: Analysis of two nationally representative surveys.
Sánchez-Pájaro, Andrés · 2025
Each unit increase in municipal education was associated with a 2.9% increase in recreational cannabis use prevalence in 2023 (up from 1.5% in 2016-17), while each unit increase in municipal income was associated with a 1.8% increase (up from 1.5%)..